As of 2025-11-30, the Relative Valuation of Biovaxys Technology Corp (BIOV.CN) is 0.05 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.26 CAD, the upside of Biovaxys Technology Corp based on Relative Valuation is -79.8%.
The range of the Relative Valuation is (0.01) - 0.09 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | -0.7x - -0.4x | -0.5x |
| Fair Price | (0.01) - 0.09 | 0.05 |
| Upside | -103.2% - -66.1% | -79.8% |
| Date | P/E |
| 2025-11-27 | -1.29 |
| 2025-11-26 | -1.24 |
| 2025-11-25 | -1.07 |
| 2025-11-24 | -1.17 |
| 2025-11-21 | -1.34 |
| 2025-11-20 | -1.36 |
| 2025-11-18 | -1.36 |
| 2025-11-17 | -1.19 |
| 2025-11-14 | -1.26 |
| 2025-11-13 | -1.26 |
| 2025-11-12 | -1.12 |
| 2025-11-11 | -1.26 |
| 2025-11-10 | -1.24 |
| 2025-11-07 | -1.17 |
| 2025-11-06 | -1.17 |
| 2025-11-05 | -1.12 |
| 2025-11-04 | -1.24 |
| 2025-11-03 | -1.26 |
| 2025-10-30 | -1.34 |
| 2025-10-29 | -1.14 |
| 2025-10-28 | -1.19 |
| 2025-10-27 | -0.92 |
| 2025-10-24 | -1.41 |
| 2025-10-23 | -1.26 |
| 2025-10-22 | -1.12 |
| 2025-10-21 | -0.97 |
| 2025-10-20 | -0.83 |
| 2025-10-17 | -1.21 |
| 2025-10-16 | -1.19 |
| 2025-10-15 | -1.26 |
| 2025-10-10 | -1.31 |
| 2025-10-09 | -1.51 |
| 2025-10-08 | -1.26 |
| 2025-10-07 | -1.38 |
| 2025-10-06 | -1.43 |
| 2025-10-02 | -1.48 |
| 2025-10-01 | -1.34 |
| 2025-09-30 | -1.34 |
| 2025-09-29 | -1.21 |
| 2025-09-26 | -1.41 |
| 2025-09-25 | -1.41 |
| 2025-09-24 | -1.26 |
| 2025-09-23 | -1.41 |
| 2025-09-22 | -1.24 |
| 2025-09-19 | -1.19 |
| 2025-09-18 | -1.41 |
| 2025-09-17 | -1.17 |
| 2025-09-16 | -1.19 |
| 2025-09-15 | -1.09 |
| 2025-09-12 | -1.21 |